Columbia Partners Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-16,036
Closed -$394K 209
2018
Q1
$394K Buy
16,036
+258
+2% +$6.77K 0.05% 201
2017
Q4
$423K Sell
15,778
-6
-0% -$153 0.06% 186
2017
Q3
$379K Buy
15,784
+2,202
+16% +$49.8K 0.05% 197
2017
Q2
$291K Buy
+13,582
New +$274K 0.04% 224
2017
Q1
Sell
-141,358
Closed -$2.53M 287
2016
Q4
$2.53M Sell
141,358
-75,400
-35% -$1.37M 0.23% 151
2016
Q3
$4.51M Sell
216,758
-55,694
-20% -$1.38M 0.35% 105
2016
Q2
$7.33M Sell
272,452
-69,810
-20% -$1.91M 0.54% 53
2016
Q1
$9.27M Buy
342,262
+1,338
+0.4% +$35.8K 0.66% 39
2015
Q4
$9.9M Buy
340,924
+45,642
+15% +$1.26M 0.69% 39
2015
Q3
$8.01M Sell
295,282
-180,946
-38% -$5.12M 0.56% 65
2015
Q2
$13M Sell
476,228
-92,484
-16% -$2.6M 0.81% 27
2015
Q1
$15.2M Sell
568,712
-21,190
-4% -$488K 0.81% 28
2014
Q4
$12.5M Sell
589,902
-12,428
-2% -$278K 0.65% 45
2014
Q3
$14.3M Sell
602,330
-9,850
-2% -$227K 0.73% 26
2014
Q2
$14.1M Sell
612,180
-17,230
-3% -$380K 0.65% 40
2014
Q1
$14.4M Sell
629,410
-8,500
-1% -$181K 0.63% 46
2013
Q4
$11.8M Sell
637,910
-14,410
-2% -$251K 0.5% 64
2013
Q3
$11M Sell
652,320
-19,950
-3% -$336K 0.49% 58
2013
Q2
$10.4M Buy
+672,270
New +$11.2M 0.49% 58

Other funds holding NVO

Columbia Partners Investment Management's NVO Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 16,036 shares — an estimated $394K sold.

Columbia Partners Investment Management first reported a position in NVO in Q2 2013 and held it in 19 quarters. The position peaked at $15.2M in Q1 2015. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 16,036 Novo Nordisk shares in Q2 2018, an estimated $394K.
  • Columbia Partners Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 19 quarters.
  • Columbia Partners Investment Management's Novo Nordisk position peaked at $15.2M in Q1 2015.
  • 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.